Categories

Sign Up to Receive the Latest Trading Tips and News from Prosper



    December 7, 2018

    Wild Ride

    The Wild Ride in the markets not only continued this week but became even more volatile!  What’s more, the intra-moves are also a wild ride – not just the closing price. In today’s video, we discuss this action and where the market may go next.

    Read Article
    December 7, 2018

    Tonix Pharmaceuticals Holding Corp Was Hammered

    Tonix Pharmaceuticals Holding Corp (TNXP) was hammered after news hit today. The news was that the company would issue $15M in new stock at $3.50 per share. The company had previously stated it would issue new shares and had also recently completed a reverse split. The stock was trading above $5 per share just before […]

    Read Article
    December 6, 2018

    If Volatility Is Your Thing, We Have A Market For You!

    The equities markets were quite volatile today, with large plunges in the S&P and Dow Jones indexes both before and after today’s open. The Dow was down almost -800 points at one point during today, before retracing nearly 50% of those losses by the middle of the session. There were multiple factors alleged to be […]

    Read Article
    December 4, 2018

    Novelion Therapeutics Inc. In the News Today

    Novelion Therapeutics Inc. (NVLN) rose sharply after market close yesterday after a major shareholder advocated for the company to explore a potential sale to another company. Our classroom has had a position in NVLN for a while where we were looking for something like this to happen, but the move was short-lived so we were […]

    Read Article
    December 3, 2018

    Tesaro Gets Bought

    The equities markets had a slightly bullish inclination today. The healthcare Tesaro, Inc. (TSRO) was up over +58% today after news hit that the company was being bought out by GlaxoSmithKline (GSK). The buyout price is $75 per share in cash, which caused GSK stock to drop over -8%. Previously in mid-November, TSRO was up […]

    Read Article
    December 3, 2018

    G20, Part 2

    In today’s video, we discuss the impact of the meeting between the US and China at the G20 summit on the markets.  There was neither a kumbaya moment nor an acrimonious and contentious meeting. The politicians did what they’re best at: They punted or kicked the can down the road.  

    Read Article
    November 30, 2018

    G20

    This weekend is an important G20 meeting in Argentina. This is a meeting of 19 individual countries and the EU, where they discuss the promotion of international financial stability.  This weekend’s meeting, however, will take on more significance than normal because of the meeting between Trump and Xi. Will they make a trade deal, or […]

    Read Article
    November 30, 2018

    Trade Talk Optimism Gives A Boost To the Markets

    The equities markets had a slightly bullish inclination today. The healthcare ETF XLV was up +0.7% a the time this content was created, whereas the biotech ETF IBB was up about +0.96%. The primary reason for the overall rise in the markets is likely the possibility of progress on trade negotiations between the United States […]

    Read Article
    November 29, 2018

    Tonix Pharmaceuticals May Have Played Their Cards Right

    Tonix Pharmaceuticals finally broke strongly to the upside today. As expected, there was pent-up speculative interest in the stock due to its recent reverse split. The stock had a 10:1 reverse split, after which it rose about $4 per share to a high of $9.60 at the time this content was created. Here is a […]

    Read Article
    November 27, 2018

    Aethlon Medical, Inc. Introduces Its Breakthrough Technology

    Aethlon Medical, Inc. was very bullish in the pre-market session. The company received breakthrough device designation from the FDA for their Hemopurifier, which is used for the treatment of cancer. According to a press release from the company, the device is a “first-in-class technology designed for the rapid depletion of cancer-promoting exosomes and life-threatening viruses”. […]

    Read Article